Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venice II: Venetoclax monotherapy in relapsed/refractory chronic lymphocytic leukemia
2016-001097-15Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of venetoclax in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), sponsored by AbbVie Inc.. Started Aug 2016; status: completed.
02
Drugs
venetoclax
03
Conditions
chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
Beyond the preview
Go deeper on 2016-001097-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001097-15.